U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07335120) titled 'A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma' on Jan. 05.
Brief Summary: LBCL is a cancer of the lymphatic system where B-cells (a type of white blood cell) experience uncontrolled growth. The standard treatment for LBCL is a combination of chemotherapy and immunotherapy, referred to as chemo-immunotherapy. Currently, the best results in the treatment of LBCL is with a chemo-immunotherapy combination called R-CHOP or Pola-R-CHP. Full doses of treatment are not suitable for elderly or frail patients due to potential to cause side effects and heart problems. Such patients either receiv...